154 related articles for article (PubMed ID: 30552766)
1. Emergence of Oncogenic-Enhancing Hepatitis B Virus X Gene Mutants in Patients Receiving Suboptimal Entecavir Treatment.
Lin CL; Chu YD; Yeh CT
Hepatology; 2019 May; 69(5):2292-2296. PubMed ID: 30552766
[No Abstract] [Full Text] [Related]
2. Gender disparity of hepatocellular carcinoma: role of hepatitis B virus X protein and androgen receptor.
Chiu YT; Ng IO
Hong Kong Med J; 2016 Jun; 22(3 Suppl 4):43-7. PubMed ID: 27390010
[No Abstract] [Full Text] [Related]
3. [Features of hepatitis B virus-related hepatocellular carcinoma].
Ishikawa T; Ichida T
Nihon Rinsho; 2001 Oct; 59 Suppl 6():435-9. PubMed ID: 11761988
[No Abstract] [Full Text] [Related]
4. Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma.
Llovet JM; Lok A
J Natl Cancer Inst; 2008 Aug; 100(16):1121-3. PubMed ID: 18695130
[No Abstract] [Full Text] [Related]
5. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization.
Li X; Zhong X; Chen ZH; Wang TT; Ma XK; Xing YF; Wu DH; Dong M; Chen J; Ruan DY; Lin ZX; Wen JY; Wei L; Wu XY; Lin Q
Asian Pac J Cancer Prev; 2015; 16(18):8665-70. PubMed ID: 26745134
[TBL] [Abstract][Full Text] [Related]
7. Entecavir and Low Genetic Barrier Antiviral Agents for Hepatocellular Carcinoma in Hepatitis B Viral Cirrhosis: Propensity Score Matching.
Li T; Qu Y; Wang Y; Lin C; Yang B; Wang L
J Coll Physicians Surg Pak; 2019 Apr; 29(4):317-323. PubMed ID: 30925952
[TBL] [Abstract][Full Text] [Related]
8. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
Jang JW; Chun JY; Park YM; Shin SK; Yoo W; Kim SO; Hong SP
Cancer Sci; 2012 Feb; 103(2):296-304. PubMed ID: 22136288
[TBL] [Abstract][Full Text] [Related]
9. Functional characterisation of hepatitis B viral X protein/microRNA-21 interaction in HBV-associated hepatocellular carcinoma.
Li CH; Chow SC; Yin DL; Ng TB; Chen YC
Hong Kong Med J; 2016 Jun; 22(3 Suppl 4):37-42. PubMed ID: 27390009
[No Abstract] [Full Text] [Related]
10. [Characteristics of mutations in hepatitis B virus X gene and preS/S gene isolated from patients with HBV-related hepatocellular carcinoma].
Xiang GM; Zhong S; Zhao C; Deng CL; Shi XL; Zhou TY; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):146-8. PubMed ID: 17362647
[No Abstract] [Full Text] [Related]
11. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
[TBL] [Abstract][Full Text] [Related]
12. Is the DNA repair system involved in hepatitis-B-virus-mediated hepatocellular carcinogenesis?
Butel JS; Lee TH; Slagle BL
Trends Microbiol; 1996 Mar; 4(3):119-24. PubMed ID: 8868091
[No Abstract] [Full Text] [Related]
13. An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults.
Lee HW; Park JY; Ahn SH
Expert Rev Gastroenterol Hepatol; 2016; 10(2):177-86. PubMed ID: 26610256
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
Chaturvedi VK; Singh A; Dubey SK; Hetta HF; John J; Singh MP
Microb Pathog; 2019 Mar; 128():184-194. PubMed ID: 30611768
[TBL] [Abstract][Full Text] [Related]
15. No expression of HBV-human chimeric fusion transcript (HBx-LINE1) among Vietnamese patients with HBV-associated hepatocellular carcinoma.
Trung NT; Hai LT; Giang DP; Hoan PQ; Binh MT; Hoan NX; Toan NL; Meyer CG; Velavan TP; Bang MH; Song LH
Ann Hepatol; 2019; 18(2):404-405. PubMed ID: 31036498
[No Abstract] [Full Text] [Related]
16. Pin1-HBx interaction: a step toward understanding the significance of hepatitis B virus genotypes in hepatocarcinogenesis.
Datta S; Banerjee A; Chandra PK; Chakravarty R
Gastroenterology; 2007 Aug; 133(2):727-8; author reply 728-9. PubMed ID: 17681194
[No Abstract] [Full Text] [Related]
17. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection.
Iavarone M; Trabut JB; Delpuech O; Carnot F; Colombo M; Kremsdorf D; Bréchot C; Thiers V
J Hepatol; 2003 Aug; 39(2):253-61. PubMed ID: 12873823
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.
Yan J; Yao Z; Hu K; Zhong Y; Li M; Xiong Z; Deng M
Dig Dis Sci; 2015 May; 60(5):1315-24. PubMed ID: 25567052
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta-regression analysis.
Zhou HY; Luo Y; Chen WD; Gong GZ
J Gastroenterol Hepatol; 2015 Jun; 30(6):977-83. PubMed ID: 25689418
[TBL] [Abstract][Full Text] [Related]
20. Preventing infection-associated cancer: from bench to hillside.
Goedert JJ
J Natl Cancer Inst; 2005 Feb; 97(4):245-6. PubMed ID: 15713953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
